NetDragon Websoft Inc (0777)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 7.915 |
|---|---|
| 52-week range | 6.394 – 12.445 |
| Return, 1 month / 3 months | −2.3% / +6.8% |
| Return, 1 year / 3 years | −36.5% / −24.1% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -46.5% |
| Average daily value traded | 10.82M HKD |
| Dividend yield | 12.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
NetDragon Websoft is a Chinese technology company based in Fuzhou that develops and operates online and mobile games, including its long-running Eudemons series of fantasy role-playing games. Through its education technology arm, it supplies interactive classroom hardware and software, such as interactive displays and learning platforms, to schools and educators. Its games serve players in China and other markets, while its education business reaches schools internationally.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 0777, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
NetDragon Websoft Inc (0777) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 7.915 on 20 October 2026.
Its price-based Market X-Ray is 65 out of 100 (a fair price profile), ranking 609 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 36.5% and over the last three months it rose 6.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -34.9% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 6.8% | ||
| 6-month return | -4.0% | ||
| 12-month return, skipping the last month | -35.0% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.5% | ||
| Liquidity | 76 · Strong | Trades actively. | |
| Average daily value traded | 10.82M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 77 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 12.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | −2.3% |
| 3 months | +6.8% |
| 6 months | −4.0% |
| 1 year | −36.5% |
| 3 years | −24.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.596 / 7.862 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.291 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Sep 2026 | HKD 0.5000 |
| 4 Jun 2026 | HKD 0.5000 |
| 10 Sep 2025 | HKD 0.5000 |
| 10 Jun 2025 | HKD 0.5000 |
| 11 Sep 2024 | HKD 0.4000 |
| 12 Jun 2024 | HKD 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.